Pharmacy supply in the UK and the questions you will be asked posts 61–90
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Members outside these two jurisdictions reading this thread should note that none of it transfers, including the parts that sound general.
I have deliberately not rounded that, because the rounding is where the argument starts.
The most useful thing anyone has posted about pharmacy supply in this category was a table of what had been measured and by whom. That is what I would want again.
Post #62 put the caveat in the right place and I want to underline it.
Shortage positions have moved several times and any statement about supply here should carry a date on the face of it.
Adding the measurement that post #64 says would settle it.
The useful distinction on pharmacy supply is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Post #62 describes the usual case. This is about the unusual one.
Speaking only to pharmacy supply as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.
Clinical guidance published for prescribers is public and answers most eligibility questions here more precisely than the discussion does.
Posted with less confidence than the sentence structure implies.
Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
On post #69 — agreed on the reasoning, with one qualification.
Whatever the answer on pharmacy supply turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
Collapsed as off-topic by two members at trust level 3 or above
Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences.
The evidence for this is thinner than the way I have phrased it suggests.
Post #72 is right about the mechanism and I think understates the practical bit.
Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.
On reflection I would soften that slightly.
Post #74 describes the usual case. This is about the unusual one.
Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating.
If that reads as pedantic, it is, and it has saved me twice.
Adding the measurement that post #74 says would settle it.
Reading this pharmacy supply thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
The version of pharmacy supply that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
That is clearer than the version I had in my head. Thank you.
Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
Taking post #77 at face value and following it one step further.
Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI.
Small point, but it is the one that usually catches people.
Collapsed as off-topic by two members at trust level 3 or above
Genuine question rather than a rhetorical one: has anyone here actually observed pharmacy supply, as opposed to read about it? The thread is long and I cannot tell.
Building on post #82 rather than restating it.
Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand your obligations.
What I can speak to on pharmacy supply is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
The arithmetic in post #82 is right; the assumption feeding it is the part to check.
Since pharmacy supply keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.
Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.
Written quickly, so the reasoning may be tighter than the wording.
Correcting an out-of-date claim in this subcategory with a source and a date is more valuable than a new topic on the same question.
I have written this out at length because the short version keeps being misread.
Availability through a private route and availability through the public system are separate questions and both change independently.
The most useful reply I ever got about pharmacy supply was a request to state my units. It sounds like pedantry and it has saved me twice.